Artificial intelligence (AI) offers a new path forward for clinical trial sponsors, contract research organizations (CROs), and research sites collaborating on trials. By replacing reactive protocols ...

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Virtual Clinical Trials Market size & share revenue was valued at ...

UK clinical trial approval times twice as fast with AI and reforms: United Kingdom Wednesday, October 8, 2025, 13:00 Hrs [IST] The time it takes to approve clinical trials in the ...

By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

UK regulators use AI and process reforms to reduce clinical trial approvals from 91 to 41 days, speeding up patient access to ...

Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD.

The genetic roots of a disease or disorder do not always grow into clear-cut, easily diagnosed clinical features. Even if a ...

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and ...

The treatment of patients with pain and co-occurring disorders presents a significant knowledge gap that necessitates a ...